Evaluation of New Morphometric Parameters of Neoangiogenesis in Human Colorectal Cancer Using Confocal Laser Endomicroscopy (CLE) and Targeted Panendothelial Markers-Reference-Cited by-同舟云学术

Evaluation of New Morphometric Parameters of Neoangiogenesis in Human Colorectal Cancer Using Confocal Laser Endomicroscopy (CLE) and Targeted Panendothelial Markers

Published:2014-03-10 Issue:3 Volume:9 Page:e91084
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ciocâlteu Adriana,Săftoiu Adrian,Cârţână Tatiana,Gruionu Lucian Gheorghe,Pirici Daniel,Georgescu Corneliu Cristian,Georgescu Claudia-Valentina,Gheonea Dan Ionuţ,Gruionu Gabriel

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Is determination of angiogenic activity in human tumours clinically useful?;LM Ellis;Eur J Cancer,1998

2. Normalization of the vasculature for treatment of cancer and other diseases;S Goel;Physiol Rev,2011

3. Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration;C Magnon;Gene Therapy,2007

4. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors;RT Tong;Cancer Res,2004

5. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions;CG Lee;Cancer Res,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of endoscopic medical device;Practical Design and Applications of Medical Devices;2024

2. The Future of Digestive Endoscopy;Pocket Guide to Advanced Endoscopy in Gastroenterology;2023

3. Diffuse and nonlinear imaging of multiscale vascular parameters for in vivo monitoring of preclinical mammary tumors;Journal of Biophotonics;2019-03-11

4. Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas;Scientific Reports;2017-08-29

5. Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial;The Lancet Oncology;2016-11